4
Tetrahedron
3. Seebach, D. Angew. Chem. Int. Ed.1979, 18, 239.
4. Corey, E. J. Pure Appl. Chem. 1967, 14, 19.
t-butyldimethyl(((3-(phenylthio)cyclohex-1-en-1-yl)oxy)silane
(2c). The general procedure was applied using 100 mg of
cyclohexenone (1.04 mmol), 233 mg of 1c and 5.0 mg of
KCN/18-crown-6 complex (0.02 mmol) in 0.8 mL of anhydrous
THF. The product was purified by column chromatography (3.0 x
9.0 cm, silica gel; Hexanes 100 %), affording 123 mg (37 %) of 2c
as a colorless oil. TLC-Rf (Hexanes, 100%) 0.23; NMR-1H (300
MHz, CDCl3) δ 7.26 (d, J = 6.6 Hz, 2H), 7.10 (dd, J = 16.0, 6.9
Hz, 3H), 4.85 (s, 1H), 3.83 (s, 1H), 1.89 (s, 3H), 1.71 – 1.43 (m,
3H), 0.78 (s, 9H), 0.00 (s, 6H); NMR-13C (126 MHz, CDCl3) δ
154.2, 136.3, 131.3, 128.8, 126.5, 104.4, 44.8, 29.8, 28.2, 25.6,
19.1, 18.0, -4.4, -4.5.
5. Zhu, C.; Cook, S. P. J. Am. Chem. Soc. 2012, 134, 13577.
6. Heguaburu, V.; Schapiro, V.; Pandolfi, E. Tetrahedron Let.
2010, 51, 6921.
7. Cohen, T.; Bennett, D. A.; Mura, A. J. J. Org. Chem. 1976, 41,
2506.
8. Debal, A.; Cuvigny, T. r. s.; Larcheveˆque, M. Tetrahedron
Let. 1977, 18, 3187.
9. Huang, P.-Q.; Zhou, W.-S. Syn. Comm. 1991, 21, 2369.
10. Kozikowski, A. P.; Jung, S. H. J. Org. Chem. 1986, 51, 3400.
11. Kim, S.; Lee, P. H. Tetrahedron Let. 1988, 29, 5413.
12. Kim, S.; Lee, P. H.; Kim, S. S. Bull. Kor. Chem. Soc. 1989, 10,
218.
13. Katritzky, A. R.; Soloducho, J.; Musgrave, R. P.; Breytenbach,
J. C. Tetrahedron Let. 1995, 36, 5491.
14. Evans, D. A.; Grimm, K. G.; Truesdale, L. K. J. Am. Chem.
Soc. 1975, 97, 3229.
Synthesis of 2-cyclohexen-1-one-3-sustituted 4. A solution of 1.0
equiv of 2b and HMPA (2.0-2.5 equiv) in anhydrous THF [0.092
M] was cooled at -78 °C (N2 atmosphere). t-BuLi (1.5 M, 2.0-2.5
equiv) was added dropwise over 5 min period. Stirring at -78 °C
was continued for 30 minutes, and then the respective electrophile
(1.5-2.0 equiv) was added and then the reaction mixture was
stirred for 30 minutes at -78 °C. The reaction temperature was
allowed to rise to room temperature for 2 hours and the reaction
was quenched with saturated NH4Cl solution. The product was
extracted with EtOAc (3 x 15 mL). The combined organic layers
were dried over Na2SO4, filtered and concentrated in vacuum. The
crude reaction was dissolved in anhydrous THF [0.069 M] and
was cooled at 0 °C. TBAF (1.0 M, 1.25 equiv) was added and the
reaction temperature was allowed to rise the room temperature and
stirred for 18 hours. At the end of this period of time, the reaction
was quenched by adding brine and the product was extracted with
EtOAc (3 x 15 mL). The combined organic layers were dried over
Na2SO4, filtered and concentrated in vacuum and the product was
purified by column chromatography on silica gel.
15. Evans, D. A.; Truesdale, L. K.; Grimm, K. G.; Nesbitt, S. L. J.
Am. Chem. Soc. 1977, 99, 5009.
16. (a) Davis, F. A.; Rizvi, S. Q. A.; Ardecky, R.; Gosciniak, D. J.;
Friedman, A. J.; Yocklovich, S. G. J. Org. Chem. 1980, 45,
1650.
(b) Synthesis of phenyl(trialkylsilyl)sulfides 1b and 1c. To a
solution of thiophenol (1.0 equiv) and the corresponding
trialkylsilyl chloride (1.1 equiv) in anhydrous THF [1.95 M],
under nitrogen atmosphere, triethylamine (1.2 equiv) dissolved
in anhydrous THF [2.37 M] was added dropwise. Immediately
the triethylammonium chloride is observed as a white solid.
After stirring for 18 hours at room temperature, the reaction
mixture was filtered through celite, the filter was washed with
10 mL of THF, and the filtrate was washed with 10 mL of an
aqueous solution of KOH (10 %) in order to eliminate the
excess of tiophenol. The organic layers were dried over
Na2SO4 and evaporated in vacuo. The crude reaction was then
distillated under reduced pressure affording the corresponding
phenyl(trialkylsilyl)sulfide 1.
Compound 4a:13 The general procedure was applied using 105 mg
of 2b (0.28 mmol), 0.10 mL of HMPA (103 mg, 0.58 mmol), t-
BuLi (0.45 mL, 1.5 M, 0.60 mmol) and 65 µL of benzaldehyde
(63 mg, 0.59 mmol) in 3.5 mL of anhydrous THF. For the
deprotection 0.36 mL of TBAF (1.0 M, 95 mg, 0.36 mmol) were
used in 4 mL anhydrous THF. The reaction crude was purified by
column chromatography (2.0
x 8.0 cm, silica gel; 55:45
Compound 1b: The general procedure was applied using 1.0
mL of thiophenol (1.073 g, 9.74 mmol), 2.3 mL of TIPSCl
(2.072 g, 10.75 mmol) in 5 mL of anhydrous THF. This
reaction afforded 2.07 g (80%) of 2b as a colorless oil. TLC-
Rf (Hexanes 100%) 0.62; bp 109 °C (9.0 mmHg); NMR-1H
(300 MHz, CDCl3) δ 7.50 (dd, J = 6.5, 3.0 Hz, 2H), 7.24 –
7.18 (m, 3H), 1.25 (ddd, J = 15.6, 13.0, 7.1 Hz, 3H), 1.09 (d, J
= 7.1 Hz, 18H); NMR-13C (75 MHz, CDCl3) δ 135.4, 131.5,
128.5, 126.6, 18.4, 13.1. Mass spectrum m/z [M+] 266,
223(100%).
Hexanes/EtOAc) affording 41 mg (71 %) of 4a as a yellow oil.
TLC-Rf (Hexanes/EtOAc 3:2) 0.23; NMR-1H (300 MHz, CDCl3) δ
7.41 – 7.30 (m, 5H), 6.35 (d, J = 1.4 Hz, 1H), 5.24 (s, 1H), 2.38 (t,
J = 6.6 Hz, 2H), 2.27 (s, 1H), 2.15 (t, J = 5.5 Hz, 2H), 1.93 (dq, J
= 12.2, 7.0, 6.3 Hz, 2H); NMR-13C (75 MHz, CDCl3) δ 200.0,
165.0, 140.4, 128.9, 128.6, 126.8, 124.0, 76.7 , 37.8, 25.9, 22.6.
Mass spectrum m/z [M+] 246, 93(84%).
Compound 4b: The general procedure was applied using 100 mg
of 2b (0.28 mmol), 0.12 mL of HMPA (124 mg, 0.69 mmol), t-
BuLi (0.45 mL, 1.5 M, 0.60 mmol) and 70 µL of m-anisaldehyde
(75 mg, 0.55 mmol) in 3.0 mL of anhydrous THF. For the
deprotection 0.33 mL of TBAF (1.0 M, 86 mg, 0.33 mmol) were
used in 4 mL anhydrous THF. The product was purified by
Compound 1c:16 The general procedure was applied using 1.0
mL of thiophenol (1.073 g, 9.74 mmol), 1.62 g of TBDMSCl
(10.75 mmol) in 5 mL of anhydrous THF. This reaction
afforded 1.173 g (54%) of 1c as a colorless oil. TLC-Rf
(Hexanes 100%) 0.55; bp 90 °C (9.0 mmHg); NMR-1H (300
MHz, CDCl3) δ 7.26 (dd, J = 6.6, 3.0 Hz, 2H), 7.08 – 7.01 (m,
3H), 0.80 (s, 9H), -0.00 (s, 6H); NMR-13C (75 MHz, CDCl3) δ
135.6, 131.5, 128.6, 126.8, 26.4, 19.0, -3.3.
column chromatography (2.0
x 10.0 cm, silica gel; 55:45
Hexanes/EtOAc) affording 24 mg (38 %) of 4b as a yellow pallid
oil. TLC-Rf (Hexanes/EtOAc 55:45) 0.30; 1H NMR (300 MHz,
CDCl3) δ 7.20 (d, J = 7.6 Hz, 3H), 6.87 – 6.78 (m, 3H), 6.27 (s,
1H), 5.14 (s, 1H), 3.74 (s, 3H), 2.34 – 2.28 (m, 2H), 2.13 – 2.07
(m, 2H), 1.86 (d, J = 6.3 Hz, 3H), 1.26 (s, 1H); 13C NMR (75
MHz, CDCl3) δ 200.09, 165.00, 159.99, 142.07, 129.90, 124.05,
119.07, 113.92, 55.29, 37.79, 25.82, 22.60.Mass spectrum m/z
[M+] 232, 232 (100%).
Synthesis of 3-phenylthio-1-(trialkylsilyloxy)cyclohex-1-ene 2: The
KCN/18-crown-6 complex was added to a well-stirred solution of
2-cyclohexenone
(1.0
equiv)
and
the
respective
phenyl(trialkylsilyl)sulfide (1.0 equiv) in freshly distilled dry THF
[1.6 M]. Stirring under nitrogen atmosphere at room temperature
was continued for 18 h and the yellow solution was concentrated
in vacuum and the products were obtained as oils and used in their
crude form.
Compound 4c: The general procedure was applied using 100 mg
of 2b (0.28 mmol), 0.12 mL of HMPA (124 mg, 0.69 mmol), t-
BuLi (0,45 mL, 1.5 M, 0.60 mmol) and 83 mg of piperonal
(dissolved in 1 mL of THF, 0.55 mmol) in 3.0 mL of anhydrous
THF. For the deprotection 0.33 mL of TBAF (1.0 M, 86 mg, 0.33
mmol) were used in 4 mL anhydrous THF. The reaction crude was
purified by column chromatography (2.0 x 8.0 cm, silica gel;
55:45 Hexanes/EtOAc) affording 18 mg (27 %) of 4c as a yellow
pallid oil. TLC-Rf (Hexanes/EtOAc 55:45) 0.30; 1H NMR (300
MHz, CDCl3) δ 6.82 (d, J = 5.3 Hz, 3H), 6.34 (d, J = 1.5 Hz, 1H),
5.98 (s, 2H), 5.15 (s, 1H), 2.44 – 2.35 (m, 3H), 2.15 (d, J = 6.0 Hz,
2H), 2.00 – 1.88 (m, 2H), 1.34 (s, 1H); 13C NMR (75 MHz,
CDCl3) δ 200.06, 165.19, 148.13, 147.79, 134.42, 123.80, 120.60,
108.35, 107.06, 101.25, 37.79, 25.99, 22.60. Mass spectrum m/z
[M+] 246.
Compound 2b: The general procedure was applied using 376 mg
of 2-cyclohexenone (3.91 mmol), 1.04 g of 1b and 12 mg of
KCN/18-crown-6 complex (0.04 mmol) in anhydrous THF (2.5
mL). The reaction crude was purified by column chromatography
(4.0 x 10.0 cm, silica gel; Hexanes 100 %), affording 847 mg (60
%) of 2b as a yellow pallid oil. TLC-Rf (Hexanes, 100%) 0.26;
NMR-1H (300 MHz, CDCl3) δ 7.39 (d, J = 7.1 Hz, 2H), 7.27 (t, J
= 7.3 Hz, 2H), 7.20 (d, J = 7.1 Hz, 1H), 4.99 (d, J = 4.4 Hz, 1H),
3.99 (d, J = 4.2 Hz, 1H), 2.14 – 1.94 (m, 3H), 1.72 (ddtq, J = 27.8,
22.2, 11.6, 5.8, 5.2 Hz, 3H), 1.17 – 0.98 (m, 21H); NMR-13C (126
MHz, CDCl3) δ 154.4, 136.4, 131.3, 128.7, 126.4, 103.7, 44.9,
29.8, 28.1, 19.2, 18.0, 12.6. MS (EI, 70 eV) m/z [M+] 361, 255
(100%).
Compound 4d: The general procedure was applied using 100 mg
of 2b (0.28 mmol), 0.12 mL of HMPA (124 mg, 0.69 mmol), t-
BuLi (0.45 mL, 1.5 M, 0.675 mmol) and 70 µL of acetophenone
(72 mg, 0.60 mmol) in 3.0 mL of anhydrous THF. For the